References
- Clin. Pharmacokinet. v.19 no.1 Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases Lauritsen,K.;Laursen,L.S.;Madsen,R.
- Med. Res. Reviews v.10 no.1 Omeprazole: The first proton pump inhibitor Lindberg,P.;Wallmark,B.;Mattsson,H.;Rikner,L.;Hoffmann,K.J.
- Scand. J. Gastroenterol. v.20 no.suppl. 108 Emerging strategies in ulcer therapy: Pumps and receptors Berglindh,T.;Sachs,G.
- Scand. J. Gastroenterol. v.20 no.suppl. 108 Localization of omeprazole and metabolites in the mouse Helander,H.F.;Ramsay,C.H.;Regardh,C.G.
- Scand. J. Gastroenterol. v.20 no.suppl. 108 Animal pharmacodynamics of omeprazole-a survey of its pharmacological properties in vivo Larsson,H.;Mattson,H.;Sundell,G.;Carlsson,E.
- Drugs v.32 Omeprazole: A preliminary review of its pharmacodynamics and pharmacokinetic properties and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome Stephen-Clissold,S.P.;Campoli-Richards,D.M.
-
Nature
v.290
Substituted benzimidazoles inhibit gastric acid secretion by blocking (
$H^+$ /$K^+$ )ATPase Fellenius,E.;Berglindh,T.;Sachs,G.;Olbe,L.;Elander,B.;Ostrand,S.E.;Wallmark,B. - Scand. J. Gastroenterol. v.20 no.suppl. 108 The mechanism of action of omeprazole-a survey of inhibitory action in vitro Wallmark,B.;Lorentzon,P.;Larsson,H.
- Clin. Pharmacokinet. v.20 no.1 Clinical pharmacology of omeprazole Colin,W.H.
-
TiPS
v.14
Reversible inhibitors of the gastric
$H^+$ /$K^+$ -transporting$ATP_{asc}$ : A new class of anti-secrstory agent Pope,A.J.;Parsons,M.E. - Eur. J. Clin. Pharmacal. v.26 Oral pharmacokinetics of omeprazole Howden,C.W.;Meredith, P,A,;Forrest,J.A.H.;Reid,J.L.
- Clin. Pharmacokinet. v.23 no.6 Pharmacokinetic study of omeprazole in elderly healthy volunteers Landahl,S.;Andersson,T.
- Scand. J. Gastroenterol. v.21 no.Suppl. 118 Omeprazole: pharmacokinetics and metabolisms of omeprazole in man Cederberg,C.;Andersson,T.
- Therapeutic Drug Monitoring v.12 The pharmacokinetics of omeprazole in humans-a study of single intravenous and oral doses Andersson,T.;Lundborg,P.
- Eur. J. Clin. Pharmacol. v.39 Pharmacokinetics of various single intravenous and oral doses of omeprazole Cederberg,C.;Andersson,T.
- Scand. J. Gastroenterol. v.20 no.suppl. 108 Development of an oral formulation of omeprazole Pilbrant,A.;Cederberg,C.
- U. S. Pat. 2. 611. 730 Medical preparation for reducing the body level of sodium Heming,A.E.
- ELSEVIER Manual of microsurgery on the laboratory rat Van dongen,J.J.;Remie,R.;Rensema,J.W.;Van wunnik,G.H.J.
- Pharmacokinetics(2nd ed.) Gibaldi,M.;Perrier,D.
- Basic clinical phamacokinetics(2nd ed.) Winter,M.E.;Anne,M.;Kimble,K.;Young,L.Y.
- Applied pharmaceutics and pharmacokinetics Shargel,L.;Yu,A.B.C.
- Manual of pharmacologic calculations with computer programs(2nd ed.) Tallarida,R.J.;Murray,R.B.
- J. Chromatogr. v.309 Detrmination of omeprazole and metabolites in plasma and urine by liquid chromatography Lagerstrom,P.O.;Persson,B.A.
- J. Chromatogr. v.571 no.1-2 Highperformance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine Aoki,I.;Okumura,M.;Yashiki,T.
- J. Chromatography v.426 Improved procedure for quantitation of omeprazole and metabolites using reverse-phase liquid-performance chromatography Amantea,M.A.;Narang,P.K.
- J. Chromatography v.278 Simultaneous HPLC analysis of omeprazole and its sulphone and sulphide metabolites in human plasma and urine Mihaly,G.W.;Prichard,P.J.;Louis,W.J.
- J. Pharmaceu. Biomedi. Analysis v.4 no.3 Fully automated gradient elution liquid chromatographic assay of omeprazole and two metabolites Grundevik,I.;Jerndal,G.;Persson,B.A.
- Archives Pharmacal Res. v.17 no.6 Determination of omeprazole in rat plasma by HPLC with column switching Shim,S.H.;Bok,S.J.;Kwon,K.I.
- Jpn. Pharmacol. Ther. v.21 no.10 胃潰瘍 十二指腸潰瘍에 대한 proton pump inhibitor의 全國共同硏究 三輪 剛;丹羽 寬文;常岡 健二
- Scand. J. Gastroenterol. v.21 Inhibition of basal and betazole- and sham-feeding-induced acid secretion by omeprazole in man Lind,T.;Cederberg,C.;Ekenved,G.;Olbe,L.
- J. Clin. pharmacol. therapeu. toxicol. v.31 no.2 Comparative bioavailability of two enteric-coated capsules of omeprazole in healthy volunteers Garg,S.K.;Chugh,Y.;Tripathi,S.K.;Kumar,N.;Sharma,P.L.
- Gastroenterol. v.88 Omeprazole: A study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage Prichard,P.J.;Yeomans,N.D.;Mihaly,G.W.;Jones,D.B.;Buckle,P.J.;Smallwood,R.A.;Louis,W.J.
- Br. J. Clin. Pharmacol. v.29 Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects Andersson,T.;Andren,N.;Cederberg,C.;Lagerstrom,P.O.;Lundborg,P.;Skanberg,I.
- Drug Invest. v.2 no.4 Pharmacokinetics of omeprazole and metabolites following single intravenous and oral doses of 40 and 80 mg Andersson,T.;Regardh,C.G.
- Gut v.29 Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man Jansen,J.B.M.J.;Lundborg,P.;Baak,L.C.;Greve,J.;Ohman,M.;Stover,C.;Rohss,K.;Lambers,C.B.H.W.
- Digestion v.44 no.suppl 1 Omeprazole: Pharmacology, pharmacokinetics and interactions Oosterhuis,B.;Jonkman,J.H.G.
- Scand. J. Gastroenterol. v.20 no.suppl 108 Pharmacokinetics and metabolism of omeprazole in animals and man-an overview Regardh,C.G.;Gabrielsson,M.;Hoffmann,K.J.;Lofberg,I.;Skanberg,I.
- J. Kor. Pharm. Sci. v.23 no.1 Bioeqivalence of entric-coated omeprazole products Kim,C.K.;Jeong,E.J.;Lee,W.K.